AACR-KidneyCAN Kidney Cancer Innovation and Discovery Grants
American Association for Cancer Research
Funding Amount
US $50,000
Deadline
Deadline not published
Grant Type
Foundation
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Geography
- Located in countries building cancer research capacities
Other requirements
- You must be a member of this organization to apply for this award - become a member.
- Applicants must be AACR Active members in good standing (dues paid for the current year).
- Nonmembers interested in this grant opportunity must submit a satisfactory application for AACR Active membership by the Application deadline.
Overview
The AACR-KidneyCAN Kidney Cancer Innovation and Discovery Grants aim to foster innovative research that translates basic discoveries into effective treatments for kidney cancer. With a funding amount of $50,000 over one year, this grant supports various research-related expenses, including personnel costs and laboratory supplies. Eligible applicants include established researchers as well as those from other cancer or biomedical fields looking to contribute to kidney cancer research. Attendance at the AACR Annual Meeting is required for grant recipients.
AACR-KidneyCAN Kidney Cancer Innovation and Discovery Grants
The AACR-KidneyCAN Kidney Cancer Innovation and Discovery Grants seeks to stimulate creative approaches to translate basic research into new treatment options for kidney cancer.
Applications are invited from researchers currently in the field as well as investigators with experience in other areas of cancer or biomedical research who have promising ideas and approaches that can be applied to kidney cancer research.
This grant provides $50,000 over one year for expenses related to the research project, which may include salary and benefits of the grant recipient, collaborator, postdoctoral or clinical research fellows, graduate students (including tuition costs associated with graduate students’ education and training), or research assistants; research/laboratory supplies; equipment; publication charges for manuscripts that pertain directly to the funded project; and other research expenses. Indirect costs are not allowable expenses.
Funding
A single amount of $50,000 USD.
Grant recipient must attend the Annual Grantee Recognition Event held during the AACR Annual Meeting to accept their grant. Up to $2,000 may be allocated from the grant to offset attendance costs. Up to $1,000 can also be utilized to attend the AACR Grantee Summit.
Eligibility
You must be a member of this organization to apply for this award - become a member. Applicants must be AACR Active members in good standing (dues paid for the current year). Nonmembers interested in this grant opportunity must submit a satisfactory application for AACR Active membership by the Application deadline. Please be informed that no dues are required for members located in countries building cancer research capacities.
Focus Areas & Funding Uses
Fields of Work
- Cancer
- Science research
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
Discovery of the Genetic Basis of Childhood Cancers and of Congenital Anomalies: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Varies
Deadline
January 11, 2027
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Up to $350,000
Deadline
November 6, 2026
Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
National Institutes of Health
Amount
$50,000 - $300,000
Deadline
November 10, 2026
Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
National Institutes of Health
Amount
$50,000 - $150,000
Deadline
November 10, 2026
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
National Institutes of Health
Amount
Up to $200,000
Deadline
November 17, 2026
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
National Institutes of Health
Amount
Up to $499,999
Deadline
January 7, 2027
Ready to apply for AACR-KidneyCAN Kidney Cancer Innovation and Discovery Grants?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found AACR-KidneyCAN Kidney Cancer Innovation and Discovery Grants. Now let's win it.